Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2010
09/14/2010US7795509 Tobacco products with reduced nicotine
09/14/2010US7795508 Soybean variety XB009C09
09/14/2010US7795507 Soybean cultivar S07-03JR457071
09/14/2010US7795506 Soybean variety XB23Q08
09/14/2010US7795505 A DNA encoding a phosphinothricin acetyltransferase protein obtained from Streptomyces sp. AB3534 strain; imparts herbicide phosphinothricin
09/14/2010US7795504 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
09/14/2010US7795503 plant cell containing a regulatory protein that can modulate expression of one or more genes involved in alkaloid biosynthesis in plants; papaverine, narcotine, noscapine, narceine, hydrastine, oripavine
09/14/2010US7795502 AtRSp gene promoters
09/14/2010US7795501 Protein regulating leaf longevity of plants, the gene thereof and their use
09/14/2010US7795500 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants
09/14/2010US7795499 by altered expression of a DR02 nucleic acid; genetic engineering; abiotic stresses
09/14/2010US7795498 Use of AtBG1 gene for the generation of transgenic plants with increased resistance to various abiotic stress
09/14/2010US7795497 Integration and expression plastid vector for stably transforming a plastid genome of a monocotyledonous or dicotyledonous plant; transfer and propagation of heterologous nucleotide sequences
09/14/2010US7795496 Transforming oviduct tissue of birds with nucleotide sequences coding mammalian polypeptides; tissue engineering
09/14/2010US7795495 utility of beta -synuclein and peptides derived therefrom as anti-amyloidogenic agents ; neurodegenerative diseases such as Alzheimer's and Parkinson's diseases; screening for new anti-amyloidogenic agents
09/14/2010US7795494 Transgenic animals capable of generating antibodies, e.g., human monoclonal antibodies, specific for the product of a gene of interest
09/14/2010US7795493 tissues, organs and cells for use in xenotransplantation
09/14/2010US7795422 Chemically synthesized siRNA molecule; nucleic acids with a pyrimidine modification; inflammatory, respiratory, pulmonary, autoimmune, cardiovascular, neurodegenerative, and/or proliferative and cancerous diseases, traits, or conditions
09/14/2010US7795421 siRNA targeting apolipoprotein B (APOB)
09/14/2010US7795420 Short interfering RNA sequences for use in treatment and prevention of diabetes, alzheimer's and cell proliferative disorders
09/14/2010US7795419 human microRNA molecules associated with viral infections; used to identify modulators of viral infections
09/14/2010US7795416 Telomerase repressor proteins and nucleic acid compositions encoding the same are provided. The subject repressor proteins bind to a repressor site in the TERT minimal promoter, e.g., a Site C site, and thereby inhibit TERT expression.
09/14/2010US7795415 nucleotide sequences encoding the kinase and conferring stress tolerance to plants upon over-expression; drought resistance
09/14/2010US7795414 Expression vector comprising nucleotide sequences coding lipid metabolism protein (LMP) for use in enhancing seed ability to store lipids, fatty acids and starches; modified seed storage proteins
09/14/2010US7795413 Nucleic acids encoding human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
09/14/2010US7795410 Compositions and methods for treating HIV infection with cupredoxin and cytochrome c
09/14/2010US7795408 Method for cloning and expression of Acc65I restriction endonuclease and Acc65I methylase in E. Coli
09/14/2010US7795407 Metastatic breast and colon cancer regulated genes
09/14/2010US7795406 Agent for treating leishmania infections
09/14/2010US7795398 for preventing oomycete infection of potato and/or tomato; disease resistant plants; Phytophthora infestans
09/14/2010US7795396 COOH-terminally added cysteine variant of the beta interferon
09/14/2010US7795395 encoding Xenorhabdus toxin complex (TC) proteins; transgenic plants and host cells expressing Xenorhabdus toxin complex (TC) proteins and having resistance to insects; pest control
09/14/2010US7795394 Saitohin gene and uses of same
09/14/2010US7795391 Protein showing enhanced expression in cancer cells
09/14/2010US7795390 Biological substance nesfatin and its related substances and uses thereof
09/14/2010US7795387 detecting the decreased transcription of messenger RNA transcribed from an RDCVF1 or RDCVF2 polypeptide, in the eye of a human, wherein said decreased transcription is diagnostic of such human's suffering from retinal dystrohy
09/14/2010US7795384 expressed with high efficiency and stability in host cells; suitable for high effectively producing short peptides without lysine residues; digesting the fusion protein with trypsinase and carboxypeptidase B, thereby forming peptides C1 and C2
09/14/2010US7795381 Helper T lymphocytes epitope for use in induction of antitumor responses in melanoma; antiproliferative agents
09/14/2010US7795235 Semi-soft c-class immunostimulatory oligonucleotides
09/14/2010US7795234 Newly identified human small intestine extracellular lactase-phlorizin hydrolase (ecLPH) gene
09/14/2010US7795232 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
09/14/2010US7795224 Tumor associated antigen peptides and use of same as anti-tumor vaccines
09/14/2010US7795214 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases
09/14/2010US7795212 such as viral myocarditis (Coxsackie virus, echovirus, polio virus) or dilated (congestive) cardiomyopathy, by binding ErbB2-ErbB4 receptors; atpase inhibitors
09/14/2010US7795182 Method for making biochips
09/14/2010US7795042 red-emitting fluorescent rhodamine dyes; photostable; useful as molecular probes; For use in assays involving staining of cells, protein binding, and/or analysis of nucleic acids (hybridization and sequencing)
09/14/2010US7795032 Methods for proliferating cardiomyocytes and recombinant vectors therefor
09/14/2010US7795031 Neurodegenerative disease; demyelination diseases; brain disorders; screening stem cells in brain; animal models; Alzheimer's, Parkinson's, Huntington's disease
09/14/2010US7795030 Methods and compositions for cellular and metabolic engineering
09/14/2010US7795028 Modulating developmental transitions in plants
09/14/2010US7795023 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
09/14/2010US7795020 Prepared from autologous lymphoma cells transfected with emm55; for canines; the modified cancer cells are highly immunogenic to the host, yet show no toxic side effects
09/14/2010US7795019 Controlling intestinal absorbtion of biopolymers via reducing genic expression of membrane eflux transport protein; predicting absorption of drugs and nutritional supplements
09/14/2010US7795018 expresses CD14, CD34, CD45, type I collagen, and HLA-DR; differentiates into osteoblasts, skeletal myoblasts or chondrocytes; obtained by culturing peripheral blood mononuclear cells (PBMCs) in vitro on fibronectin; noninvasive; will not cause rejection at the time of cell transplantation
09/14/2010US7795017 plasmid constructs useful for the delivery of DNA vaccines; having a transcription cassette capable of directing the expression of a vaccine nucleic acid insert encoding immunogens derived from any pathogen, including fungi, bacteria and viruses
09/14/2010US7795016 P185 Neu-encoding DNA and therapeutical uses thereof
09/14/2010US7795015 Nucleotide squences coding preferential antibody for prevention of and treatment of infections
09/14/2010US7795003 Animal feed containing polypeptides
09/14/2010US7795002 Which lack fucose and sialic acid residues; recombinant host cells; mannosidases
09/14/2010US7795001 Comprises polynucleotides coding proteins associated with generating macrolide antibiotics; bactericides; polyketide synthase
09/14/2010US7794998 vectors and vaccines for use in humans against infection and disease; human T-lymphotropic virus
09/14/2010US7794996 Viral polymerase with enhanced activity and specificity; gene expression analysis; CDNA libraries
09/14/2010US7794995 use of several sequential steps, including subcellular fractionation to isolate a plasma membrane fraction and the use of gel filtration or chromatography that separates molecules according to their size or affinity; drug screening
09/14/2010US7794994 Enzyme-based system and sensor for measuring acetone
09/14/2010US7794993 Carbonyl reductase, gene thereof and method of using the same
09/14/2010US7794988 using a modified bacterium belonging to genus Escherichia; culturing
09/14/2010US7794981 Prosuction of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of camelidae
09/14/2010US7794980 comprising an autoprocessing segment having an amino acid sequence being capable of auto-cleavage
09/14/2010US7794978 Cells comprise orthogonal aminoacyl-tRNA synthetase and p-acetyl-L-phenylalanine; site-directed mutagenesis; kits
09/14/2010US7794977 Using transgenic cell comprising stabilizing-antirepression sequences (STAR) a bioreactor for production of preferential polypeptides
09/14/2010US7794976 Using expression vector comprising 3' untranslated region of immunoglobulin light chain and an epstein-barr viral origin of replication as gene transfer vehicle for expression of heterologus gene sequences in cells
09/14/2010US7794975 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
09/14/2010US7794973 Nucleotide sequences coding protein for use in the treatment of blood disorders; cDNA derived from mouse yolk sacs
09/14/2010US7794972 Benzoate-and anthranilate-inducible promoters
09/14/2010US7794971 cloning and stably maintaining a DNA sequence encoding a foreign product in a host cell; comprises a poly(A) polymerase gene that is operably joined to a conditionally inducible promoter
09/14/2010US7794967 Using small RNA molecules comprising metal binding region/domain as tool in detection of modulators which treat and prevent cell proliferation disorders
09/14/2010US7794962 capable of processing intron-containing eukaryotic genes, and also can carry out post-translational processing steps such as glyclosylation and protein folding
09/14/2010US7794957 Eukaryotic genes involved in adult lifespan regulation
09/14/2010US7794955 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell; drug screening for their ability to interact with transmembrane proteins
09/14/2010US7794945 Conjugates between a minor groove binding the trimer of 1,2-dihydro- (3H)-pyrrolo(3,3-e)indole-7-carboxylate and an oligonucleotide and forms stable hybrids with complementary target sequence
09/14/2010US7794942 Expression vector comprising viral polyprotein for use as tool in developng vaccine against hepatitis-C infection; improving transfection efficiencies
09/14/2010US7794932 Composition for recovering ribonucleic acids from any source
09/14/2010US7794931 mRNAs serve as metabolite-sensitive genetic switches for regulating gene expression; nonimmunogenic aptamer domains are swapped to create new recognition domain which causes genetic modulation with effector compounds; drug screening; gene therapy
09/14/2010US7794929 Detecting a colorectal cancer and/or gastric cancer, detecting selective hybridization of nucleic acid, therapeutic treatment of a cancer, a kit contains oligonucleotide
09/14/2010US7794927 Method for identifying agonists or antagonists of the G-protein coupled receptor mas-like 1
09/14/2010US7794799 Process for producing array plate for biomolecules having hydrophilic and hydrophobic regions
09/14/2010US7794728 Induction immunology response; vaccines
09/14/2010US7794725 Isolated peptides derived from human immunodeficiency virus types 1 and 2 containing fusion inhibitory domains
09/14/2010US7794723 treatment or prophylaxis of cancer using proteins or peptides that elicit T cell mediated immunity; vaccination
09/14/2010US7794719 variable regions peptides for immunizing against amyloid plaque formation; biodrug for dementia, Alzheimer's disease, neuropathy, Down's syndrome, Creutzfeld Jacob disease, Parkinson's disease, amyotropic lateral sclerosis; neuroprotectants; hemostatic agent
09/14/2010US7794715 T-cell immune response cDNA 7 (TIRC7) antagonist; rheumatoid arthritis; comprising all three complementarity determining regions (CDRs) of the VH and all three complementarity determining regions (CDRs) of the VL variable regions
09/14/2010US7794707 ACE2 activation for treatment of heart, lung and kidney disease and hypertension
09/14/2010US7794703 Method for production and delivery of a protein in vivo
09/14/2010US7794696 Made from divinyl ethers and diols that may be dimethylol terminated polyamines, polyamides or dendrimers; may be reacted with polynucleotides to form complexes for cell transfection
09/14/2010CA2484525C Maize clavata3-like polynucleotide sequences and methods of use
09/14/2010CA2386231C Membrane translocating peptide drug delivery system
09/14/2010CA2373314C Nucleic acid-based detection
09/14/2010CA2370393C Dna sequence, and recombinant production of a gramineae allergen
09/14/2010CA2370123C Polynucleotide probes for detection and quantitation of actinomycetes
09/14/2010CA2364146C Method for processing a nucleic acid sample by oscillating a cartridge, a system and a cartridge for performing such a method